Antenatal prevention of neonatal group B streptococcal infection

Reviews in Gynaecological and Perinatal Practice

Volumn 6, Issue 3-4, 2006, Pages 218-225

  Beal, Sophie ^a   Dancer, Stephanie ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antibiotic prophylaxis; Group B streptococcus; Pregnancy complications (infectious); Screening; Streptococcus agalactiae; Vaccines

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHLORHEXIDINE; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; PENICILLIN G; PLACEBO; STREPTOCOCCUS VACCINE;

ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL TRIAL; DELIVERY; DRUG CHOICE; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; INTRAPARTUM CARE; MATERNAL DISEASE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; NEWBORN; NEWBORN INFECTION; NONHUMAN; PATIENT SELECTION; PENICILLIN ALLERGY; PRACTICE GUIDELINE; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SEROTYPING; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VAGINA; VERTICAL TRANSMISSION;

EID: 33747848949     PISSN: 18712320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rigapp.2006.05.006     Document Type: Article

References (42)

1. Baker C.J., and Edwards M.S. Group B streptococcal infections. In: Remington J., and Klein J.O. (Eds). Infectious diseases of the newborn and infant. 5th ed. (2000), Philadelphia, PA, WB Saunders 1091-1156
2. Gibbs R.S., Schrag S., and Schuchat A. Perinatal infections due to Group B streptococcus. Obstet Gynecol 104 5 Pt 1 (2004) 1062-1076
3. Boyer K.M., and Gotoff S.P. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. New Engl J Med 314 (1986) 1665-1669
4. Centers for Disease Control Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. Morb Mortal Wkly Rep 51 (2002) 1-22
5. Royal College of Obstetricians and Gynaecologists. Prevention of early onset neonatal group B streptococcal disease. Guideline No 36. London: RCOG; 2003.
6. Canadian Task Force on Preventative Health Care. Prevention of early-onset group B streptococcal disease in the newborn: systematic review and recommendations. CTFPHC Technical Report 01-6. London ON: CTF; 2001.
7. Anthony B.F., Eisenstadt R., Carter J., Kim K.S., and Hobel C.J. Genital and intestinal carriage of group B streptococci during pregnancy. J Infect Dis 143 (1981) 761-766
8. Pass M.A., Gray B.M., Khare S., and Dillon Jr. H.C. Prospective studies of group B streptococcal infections in infants. J Pediatr 95 (1979) 437-443
9. Schuchat A., Deaver-Robinson K., Plikaytis B.D., Zangwill K.M., Mohle-Boetani J., and Wenger J.D. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 13 (1994) 623-629
10. Heath P.T., Balfour G., Weisner A.M., Efstratiou A., Lamagni T.L., Tighe H., et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 363 (2004) 292-294
11. Weisner A.M., Johnson A.P., Lamagni T.L., Arnold E., Warner M., Heath P.T., et al. Characterisation of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis 38 (2004) 1203-1208
12. Noya F.J.D., Rench M.A., Metzger T.G., Colman G., Naidoo J., and Baker C.J. Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis 155 6 (1987) 1135-1144
13. Boyer K.M., Gadzala C.A., Kelly P.D., Burd L.I., and Gotoff S.P. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis 148 (1983) 802-809
14. Ferreri P., and Blair L.L. Pharyngeal carriage of group B streptococci: detection by three methods. J Clin Microbiol 6 (1977) 136-139
15. Yancey M.K., Armer T., Clark P., and Duff P. Assessment of rapid identification tests for genital carriage of group B streptococci. Obstet Gynecol 80 (1992) 1038-1047
16. Bergeron M.G., Danbing K., Ménard C., Francois F.J., Gagnon M., Bernier M., et al. Rapid detection of group B streptococci in pregnant women at delivery. New Engl J Med 343 (2000) 175-179
17. Slotved H.C., Elliott J., Thompson T., and Konradsen H.B. Latex assay for serotyping group B Streptococcus isolates. J Clin Microbiol 41 (2003) 4445-4447
18. Hall R.T., Barnes W., Krishnan L., Harris D.J., Rhodes P.G., Fayez J., et al. Antibiotic treatment of parturient women colonized with group B streptococci. Am J Obstet Gynecol 124 (1976) 630-634
19. Dancer S.J. How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infect Dis 4 10 (2004) 611-619
20. Kenyon S.L., Taylor D.J., Tarnow-Mordi W., and ORACLE Collaborative Group. Broad-spectrum antibiotics for pre-term, pre-labour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 357 9261 (2001) 979-988
21. Gilbert R.E., Pike K., Kenyon S.L., Tarnow-Mordi W., and Taylor D.J. The effect of pre-partum antibiotics on the type of neonatal bacteraemia: insights from the MRC ORACLE trials. BJOG 112 6 (2005) 830-832
22. Mercer B.M., Miodovnik M., Thurnau G.R., Goldenberg R.L., Das A.F., Ramsey R.D., et al. Antibiotic therapy for reduction of infant morbidity after pre-term premature rupture of the membranes. A randomized controlled trial. JAMA 278 12 (1997) 989-995
23. Hannah M.E., Ohlsson A., Wang E.E., Matlow A., Foster G.A., Willan A.R., et al. Maternal colonisation with group B streptococcus and pre-labour rupture of membranes at term: the role of induction of labour. Term PROM Study Group. Am J Obstet Gynecol 177 4 (1997) 780-785
24. Ramus R.M., McIntyre D.D., and Wendel Jr. G.D. Antibiotic prophylaxis for group B Streptococcus is not necessary with elective caesarean section at term (abstract). Am J Obstet Gynecol 180 (1999) S85
25. Berkowitz K., Regan J.A., and Greenberg E. Antibiotic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol 28 1 (1990) 5-7
26. Morales W.J., Dickey S.S., Bornick P., and Lim D.V. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am J Obstet Gynecol 181 2 (1999) 310-314
27. Joseph T.A., Pyati S.P., and Jacobs N. Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. Arch Pediatr Adolesc Med 152 1 (1998) 35-40
28. Towers C.V., Carr M.H., Padilla G., and Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 179 4 (1998) 879-883
29. Edwards R.K., Clark P., Sistrom C.L., and Duff P. Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens. Obstet Gynecol 100 3 (2002) 534-539
30. Glasgow T.S., Young P.C., Wallin J., Kwok C., Stoddard G., Firth S., et al. Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants. Pediatrics 116 3 (2005) 696-702
31. Centers for Disease Control Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. Morb Mortal Wkly Rep 45 RR7 (1996) 1-24
32. Schrag S.J., Zell E.R., Lynfield R., Roome A., Arnold K.E., Craig A.S., et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. New Engl J Med 347 4 (2002) 233-239
33. Mohle-Boetani J.C., Schuchat A., Plikaytis B.D., Smith J.D., and Broome C.V. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA 270 12 (1993) 1442-1448
34. Fargason Jr. C.A., Peralta-Carcelen M., Rouse D.J., Cutter G.R., and Goldenberg R.L. The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease. Obstet Gynecol 90 3 (1997) 347-352
35. Stade B., Shah V., and Ohlsson A. Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection [Systematic Review]. Cochrane Pregnancy and Childbirth Group. Cochrane Database Syst Rev 4 (2005)
36. Burman L.G., Christensen P., Christensen K., Fryklund B., Helgesson A.M., Svenningsen N.W., et al. Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. The Swedish Chlorhexidine Study Group. Lancet 340 8811 (1992) 65-69
37. Taha T.E., Biggar R.J., Broadhead R.L., Mtimavalye L.A., Miotti P.G., Justesen A.B., et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity in Malawi: clinical trial. Br Med J 315 (1997) 216-220
38. Stray-Pedersen B., Bergan T., Hafstad A., Normann E., Grogaard J., and Vangdal M. Vaginal disinfection with chlorhexidine during childbirth. Int J Antimicrob Agents 12 (1999) 245-251
39. Baker C.J., and Kasper D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. New Engl J Med 294 (1976) 753-756
40. Kasper D.L., Paoletti L.C., Wessels M.R., Guttormsen H.K., Carey V.J., Jennings H.L., et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest 98 (1996) 2308-2314
41. Baker C.J., and Edwards M.S. Group B streptococcal conjugate vaccines. Arch Dis Child 88 5 (2003) 375-378
42. Maione D., Margarit I., Rinaudo C.D., Masignani V., Mora M., Scarselli M., et al. Identification of a universal group B streptococcus vaccine by multiple genome screen. Science 309 5731 (2005) 148-150